Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2067 of 6351
-
Quick breast MRI could speed up cancer detection
Diagnosis OngoingThe purpose of this study is to use a magnetic resonance imaging (MRI) sequence called golden-angle radial compressed sensing and parallel imaging (GRASP) as a noninvasive and fast way to measure the wash-in contrast (dye) in the breast. MRI uses a strong magnetic field and radio…
Sponsor: NYU Langone Health • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Kidney transplant breakthrough: could this be the end of lifelong pills?
Disease control CompletedAnti-rejection medicines, also known as immunosuppressive drugs, are prescribed to organ transplant recipients to prevent rejection of the new organ. Long-term use of these medicines places transplant recipients at higher risk of serious infections and certain types of cancer. T…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a gentler dose of an oral chemo drug help MDS patients avoid transfusions?
Disease control CompletedMulticenter, open-label study of various ASTX727 LD doses and schedules to assess safety, pharmacodynamics, pharmacokinetics, and hematologic response in subjects with International Prognostic Scoring System (IPSS) risk category of low-risk or Intermediate-1 MDS. This study will …
Phase 1/2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Blood tests could spot pancreas cancer sooner
Knowledge-focused Recruiting nowIdentifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The i…
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Common antibiotic could tame rare calcium disorder
Disease control Recruiting nowThis study evaluates the efficacy of rifampin in the treatment of hypercalcemia and/or hypercalciuria in participants with at least one inactivating mutation of the CYP24A1 gene. Eligible subjects will receive rifampin for a total of 16 weeks during this study.
Phase 2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a new dose of selexipag help kids with rare lung disease?
Disease control OngoingThe purpose of this study to confirm the selexipag starting dose(s), selected based on pharmacokinetic (PK) extrapolation from adults, that leads to similar exposure as adults doses in children from greater than or equal to (\>=) 2 to less than (˂) 18 years of age with Pulmonary …
Phase 2 • Sponsor: Actelion • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New combo aims to fight tough bladder cancer
Disease control OngoingThis phase II trial studies the side effects of atezolizumab with or without eribulin mesylate and how well they work in treating patients with urothelial cancer that has come back (recurrent), spread to nearby tissues or lymph nodes (locally advanced), or spread from where it fi…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Experimental cell therapy targets deadly childhood brain cancer
Disease control Stopped earlyThe standard of care for children with DIPG includes focal radiotherapy (RT) but outcomes have remained dismal despite this treatment. The addition of oral Temozolomide (TMZ) concurrently with RT followed by monthly TMZ was also found to be safe but ineffective. Recent studies in…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New radiation approach offers hope for inoperable breast cancer
Disease control OngoingThis is a prospective, single institution, phase I-II study of stereotactic body radiotherapy (SBRT) for unresected breast cancer. Twenty-four patients with advanced breast cancer who are not candidates for surgery (metastatic disease, unresectable, medically inoperable) or decli…
Sponsor: Toronto Sunnybrook Regional Cancer Centre • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
Targeted drug shows promise as maintenance after transplant for rare blood cancers
Disease control CompletedThis research study is studying a targeted therapy drug as a possible treatment for IDH2 mutant acute myeloid leukemia or chronic myelomonocytic leukemia while undergoing hematopoietic stem cell transplantation. The drug involved in this study is: -Enasidenib.
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
5-Minute MRI scan could spot hidden breast cancers without needles or dye
Diagnosis OngoingDiffusion-weighted imaging (DWI) is a short (under 5 minutes) non-contrast MRI technique that has shown promise for the detection and characterization of breast cancer. Our preliminary data has shown that DWI holds potential for detecting mammographically and clinically-occult br…
Sponsor: University of Washington • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to boost mesothelioma surgery success
Disease control OngoingThis phase I pilot trial studies how well atezolizumab, pemetrexed disodium, cisplatin, and surgery with or without radiation therapy works in treating patients with stage I-III pleural malignant mesothelioma. Immunotherapy with monoclonal antibodies, such as atezolizumab, may he…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug cocktail shows promise for rare sarcomas
Disease control CompletedThis study is designed to test the safety and efficacy of the combination of lenvatinib, a drug that can inhibit the growth of supplying vessels around the tumors, and eribulin, a chemotherapy drug that targets the cancer cell during mitosis, in inoperable or metastatic adipocyti…
Phase 1/2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New scan could spot hidden tumors more accurately
Diagnosis OngoingNeuroendocrine tumours (NETs) are generally slow growing, but some can be aggressive and resistant to treatment. Compared to healthy cells, the surface of these tumor cells has a greater number of special molecules called somatostatin receptors (SSTR). Somatostatin receptor scint…
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Exercise and diet program aims to keep seniors on their feet
Prevention OngoingAccording to several reports, the proportion of people aged 80yrs or older will be doubled within the next 25y, reaching 10% of the global population. Furthermore, the health life expectancy at 65y is 10.4y which remains much lower than the general life expectancy. As a result, t…
Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 26, 2026 14:34 UTC
-
Special formula may shield At-Risk babies from allergies
Prevention CompletedA multi-center, prospective, randomized, controlled, doubleblind intervention clinical Trial is performed to proof the efficiency of hydrolyzed infant formula showing a risk reduction of developing an allergy.
Sponsor: HiPP GmbH & Co. Vertrieb KG • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Inside the hoarding brain: can scans reveal why letting go is so hard?
Knowledge-focused OngoingThe purpose of this study is to understand the neural mechanisms of decision making in hoarding disorder.
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New pill could let EPP patients enjoy the sun without pain
Symptom relief CompletedThe purpose of this study is to investigate the efficacy and safety of MT-7117 on sunlight exposure duration without symptoms and tolerance in subjects with EPP.
Phase 2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Second-Chance radiation: new hope for recurrent prostate cancer?
Disease control CompletedBackground: Prostate cancer is the second leading cause of cancer death in United States (U.S.) men. Radiation is an effective treatment for most patients with localized prostate cancer, but sometimes the tumor returns. Researchers want to see if a highly focused type of radiati…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Proton vs. photon: which radiation is kinder to prostate cancer patients?
Disease control OngoingThis study is a large, prospective, pragmatic, controlled comparison of patient-centric outcomes \[quality of life (QOL), toxicity, and disease control\] between parallel cohorts of men with prostate cancer treated simultaneously at proton therapy facilities and at geographically…
Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC